Skip to content
ClearheadLab
Explore

A calm evidence note

Statins and Brain Fog: What the Evidence Actually Shows

Randomized trials found no average decline in cognitive test performance with statins. Learn what rare memory reports and studies of side effects can tell you.

Written with care by Nadia BrooksUpdated
On this page

Our clearest pick

CoreAge Rx

From $93/mo

NAD+ nasal spray or injection advertised from $93/month, with online clinical review.

Check availability
Form
Nasal spray + injection
Pricing
Varies by plan
Review
Clinician-reviewed intake
Pharmacy
Not named

Advertising disclosure · we may earn a commission if you start through this link, at no extra cost to you. This is a note on provider value, not a promise about focus, and what we write about the product is the same either way.

Also compared

HealthRX

From $134/mo

Publishes its whole price ladder in the open — both routes, with the provider visit, the supplies and the shipping already inside the figure.

See all 61 providers compared

Some people report forgetfulness or trouble thinking while taking a statin. In randomized trials, people assigned to statins did not perform worse on cognitive tests on average than people assigned to placebo.1 The prescribing information also describes rare reports of cognitive symptoms after approval.12 If you notice a change, tell your prescriber before stopping or changing your dose.

Bring a timeline of when the symptoms started and what changed around that time. Our guide to medications that can contribute to brain fog explains why a review of your full medication list can help.

What the big trials and reviews actually found

Start with the strongest evidence, because it points clearly in one direction. A systematic review and meta-analysis of randomized controlled trials asked the direct question — do statins impair cognition? — and concluded they do not1. Randomized trials are the gold standard precisely because they remove the bias of people who expect a drug to harm them; when you compare statin to placebo blindly, the cognitive difference does not appear.

The reassurance gets stronger when you look at aggressive cholesterol lowering. In a dedicated cognitive-function study nested within a large cardiovascular outcomes trial (EBBINGHAUS), driving LDL cholesterol to very low levels produced no detectable harm to memory or executive function compared with placebo2. A separate long-term analysis confirmed cognitive safety even when LDL was pushed to extremely low levels for years3. And in the elderly — the group most worried about memory — the PROSPER trial randomized older adults at vascular risk to pravastatin or placebo4 using a carefully designed battery of cognitive tests5, and statin therapy did not accelerate cognitive decline. Stepping back to the longest horizon, a 2025 systematic review and meta-analysis of cohort studies found no signal that statins increase dementia or Alzheimer's risk — if anything the observational data lean the other way6, and a 2026 review revisiting statins and cognition in older adults reached the same measured, non-alarming conclusion7. Across the best evidence we have, the average effect of statins on cognition is not harm.

What the evidence supports

  • Statins → cognitive decline (on average)No evidence

    RCT meta-analysis, intensive LDL-lowering study, PROSPER elderly trial, and cohort dementia data all show no harm.

  • How often expectations explain brain fogNo evidence

    ASCOT-LLA had too few cognitive cases for analysis. SAMSON measured overall symptom intensity.

  • Rare reports of cognitive symptomsWeak evidence

    Prescribing information describes generally reversible symptoms. Timing varies.

Each source answers a different question about cognition or symptom reporting.

What the nocebo studies measured

The nocebo effect describes real symptoms that can arise when someone expects a treatment to cause side effects. Some statin trials can help explain how expectations affect symptom reporting.

ASCOT-LLA found a difference in muscle symptom reporting once participants knew whether they were taking a statin. The trial recorded too few cases of cognitive impairment for a reliable analysis of that outcome.8 In SAMSON, participants reported similar overall symptom scores during statin and placebo months.9 These findings help explain how expectations can affect symptoms overall. Neither study estimated how often that explains brain fog.

How to handle a statin fog concern

Don't stop on your own

Statins prevent heart attacks and strokes

Raise it with your prescriber

Describe the timing, symptoms and other medication changes

Agree on a plan

Ask whether a supervised medication change makes sense

Review symptoms and treatment options with your prescriber before changing your dose.

What the prescribing information says

The atorvastatin prescribing information describes rare reports of memory problems and confusion across statins. These reports generally described symptoms that resolved after the statin was stopped, with timing varying from person to person.12 Published case reports describe improvement in some patients.1011 A report can flag a possible side effect, while determining the cause of an individual symptom takes clinical assessment.

What to discuss with your prescriber

Statins help prevent heart attacks and strokes. If your thinking has changed, talk with your prescriber about the symptoms and the reason you take the statin before changing your dose.

Tell your prescriber when the symptoms started, what other medicines or doses changed, and how the symptoms affect your day. They can review other possible causes of brain fog and decide whether a supervised medication change makes sense.

The bottom line

Randomized trials found no average decline in cognitive test performance on statins.145 Rare reports describe memory or thinking symptoms that generally resolved after stopping.12 If you are experiencing symptoms, discuss them with your prescriber before changing the medication.

A few gentle questions

Do statins cause brain fog?

Randomized trials found no average decline on cognitive tests. Prescribing information describes rare reports of memory problems and confusion. Tell your prescriber if you notice a change.

What is the nocebo effect with statins?

Expectations can contribute to real symptoms. In SAMSON, overall symptom scores were similar during statin and placebo months. These studies did not establish how often expectations explain brain fog.

Should I stop my statin if I feel foggy?

Talk with your prescriber before stopping or changing your statin. Describe the symptoms and their timing. Your prescriber can assess other possible causes and discuss whether a supervised medication change makes sense.

Can statin memory problems be reversed?

Prescribing information describes rare reports of memory or thinking symptoms that generally resolved after discontinuation. The timing varies. Talk with your prescriber before changing your dose.

Where this comes from

  1. Ott BR, Daiello LA, Dahabreh IJ, et al. (2015). Do statins impair cognition? A systematic review and meta-analysis of randomized controlled trials.. Journal of General Internal Medicine. https://pubmed.ncbi.nlm.nih.gov/25575908/
  2. Giugliano RP, Mach F, Zavitz K, et al. (2017). Cognitive Function in a Randomized Trial of Evolocumab.. New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/28813214/
  3. Zimerman A, Gibson CM, Pedersen TR, et al. (2025). Long-Term Cognitive Safety of Achieving Very Low LDL Cholesterol with Evolocumab.. NEJM Evidence. https://pubmed.ncbi.nlm.nih.gov/39718423/
  4. Shepherd J, Blauw GJ, Murphy MB, et al. (2002). Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.. The Lancet. https://pubmed.ncbi.nlm.nih.gov/12457784/
  5. Houx PJ, Shepherd J, Blauw GJ, et al. (2002). Testing cognitive function in elderly populations: the PROSPER study. PROspective Study of Pravastatin in the Elderly at Risk.. Journal of Neurology, Neurosurgery & Psychiatry. https://pubmed.ncbi.nlm.nih.gov/12235304/
  6. Du Y, et al. (2025). The role of statins in dementia or Alzheimer's disease incidence: a systematic review and meta-analysis of cohort studies.. Frontiers in Pharmacology. https://pubmed.ncbi.nlm.nih.gov/39963242/
  7. Liu Y, et al. (2026). Brain, benefit, or burden? Revisiting statins and cognitive function in older adults.. GeroScience. https://pubmed.ncbi.nlm.nih.gov/42010230/
  8. Gupta A, Thompson D, Whitehouse A, et al. (2017). Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA).. The Lancet. https://pubmed.ncbi.nlm.nih.gov/28476288/
  9. Howard JP, Wood FA, Finegold JA, et al. (2021). Side Effect Patterns in a Crossover Trial of Statin, Placebo, and No Treatment (SAMSON).. Journal of the American College of Cardiology. https://pubmed.ncbi.nlm.nih.gov/34531021/
  10. Suraweera C, de Silva V, Hanwella R (2016). Simvastatin-induced cognitive dysfunction: two case reports.. Journal of Medical Case Reports. https://pubmed.ncbi.nlm.nih.gov/27048383/
  11. Okeahialam BN (2015). Reversal of statin-induced memory dysfunction by co-enzyme Q10: a case report.. Vascular Health and Risk Management. https://pubmed.ncbi.nlm.nih.gov/26604775/
  12. Pfizer (2024). Lipitor prescribing information, section 6.2 (Postmarketing Experience).. DailyMed. https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=a60cc18b-0631-4cf0-b021-9f52224ece65

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.